Literature DB >> 14746595

Effects of topical antiglaucoma drugs on apoptosis rates of conjunctival epithelial cells in glaucoma patients.

Aysun Sanal Doğan1, Mehmet Orhan, Figen Söylemezoğlu, Murat Irkeç, Banu Bozkurt.   

Abstract

BACKGROUND: To investigate the effects of topical antiglaucoma drugs on apoptosis rates of conjunctival epithelial cells in vivo.
METHODS: Specimens were obtained from the bulbar conjunctiva of 30 patients who underwent either cataract or glaucoma surgery. Of these 30 patients, 14 had glaucoma and received topical antiglaucoma drugs. The 16 patients in the control group had neither systemic nor ocular disease except cataract and they did not receive any medications. TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling) method was used to show the apoptosis of the conjunctival epithelial cells.
RESULTS: Increased apoptosis rates were detected in specimens of patients who were on topical antiglaucoma therapy (mean +/- SD 0.208 +/- 0.154) when compared with the healthy subjects (mean +/- SD 0.083 +/- 0.102; P = 0.013). The apoptosis rates did not differ according to type, number or duration of drugs.
CONCLUSIONS: The apoptosis observed in the conjunctival epithelial cells might be due to the preservative benzalkonium chloride in the antiglaucoma medications because the apoptosis rates did not differ in patients using different types of medications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14746595     DOI: 10.1046/j.1442-9071.2003.00760.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  5 in total

Review 1.  Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.

Authors:  J Javier Servat; C Robert Bernardino
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

2.  Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study.

Authors:  Pinnita Prabhasawat; Ngamkae Ruangvaravate; Nattaporn Tesavibul; Maneerat Thewthong
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-19       Impact factor: 2.671

3.  Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits.

Authors:  Ichiro Kawaguchi; Akira Kobayashi; Tomomi Higashide; Yasuhiro Takeji; Kazushi Sakurai; Chiaki Kawaguchi; Kazuhisa Sugiyama
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

4.  Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography.

Authors:  Makoto Gozawa; Yoshihiro Takamura; Kentaro Iwasaki; Shogo Arimura; Masaru Inatani
Journal:  BMC Ophthalmol       Date:  2020-06-19       Impact factor: 2.209

5.  Therapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma Medications.

Authors:  Xing Liu; Fen-Fen Yu; Yi-Min Zhong; Xin-Xing Guo; Zhen Mao
Journal:  Chin Med J (Engl)       Date:  2015-09-20       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.